Safety Rates Drug Report: LEVETIRACETAM. Gastrooesophageal reflux disease adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: LEVETIRACETAM. Injury: Gastrooesophageal reflux disease Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 11 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
126496501	LEVETIRACETAM.	Gastrooesophageal reflux disease	SANDOZ	0.00		0	20160812	DE
126614831	LEVETIRACETAM.	Gastrooesophageal reflux disease	MYLAN	0.00		0	20160817	DE
126709411	LEVETIRACETAM.	Gastrooesophageal reflux disease	ACCORD	2.00 WK	F	4 KG	20160822	DE
126711491	LEVETIRACETAM.	Gastrooesophageal reflux disease	DR REDDYS	0.00	F	4 KG	20160822	DE
126713981	LEVETIRACETAM.	Gastrooesophageal reflux disease	RANBAXY	0.00	F	0	20160822	DE
126715971	LEVETIRACETAM.	Gastrooesophageal reflux disease	TEVA	0.00 YR	F	4 KG	20160822	DE
126740022	LEVETIRACETAM.	Gastrooesophageal reflux disease	UCB	-0.73 YR	F	4 KG	20160826	DE
126760471	LEVETIRACETAM.	Gastrooesophageal reflux disease	AUROBINDO	0.00	F	4 KG	20160823	DE
126894871	LEVETIRACETAM.	Gastrooesophageal reflux disease	GLAXOSMITHKLINE	2.00 WK	F	0	20160826	DE
126970341	LEVETIRACETAM.	Gastrooesophageal reflux disease	LUPIN	0.00	F	4 KG	20160830	DE
127787461	LEVETIRACETAM.	Gastrooesophageal reflux disease	HETERO	1.00 MON	F	4 KG	20160926	DE

|< 1/2 << Previous Page Page 1

Total Records: 11 Number of Pages: 1

Execution Time: 0.024734973907471 seconds (ucode:4928614). Developed by: James D. Barger